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THE operative management of patients with congenital or acquired heart disease is often complicated by the occurrence of ventricular arrhythmias. Bigeminal rhythm or premature ventricular contractions are frequently noted with the induction of anesthesia, with tracheal intubation, during dissection and manipulation of the heart and great vessels, and with nasotracheal aspiration in the postoperative period. Their initial occurrence is most often related to a temporary period of hypoxia, but in many patients, particularly those with advanced myocardial disease accompanying an acquired valvular lesion, premature contractions may persist or progress to sustained ventricular tachyeardia even after the precipitating hypoxia has been corrected. Under these circumstances, the administration of an effective antiarrhythmic agent is indicated, not only to restore a normal rhythm, but, more importantly, to prevent progression of the abnormality to ventricular fibrillation.
In the past, procaine and the longer-acting related compound, procaine amide, have been most widely employed for the treatment of the various ventricular arrhythmias occurring in the course of cardiac operations. [1] [2] [3] These compounds, however, cause significant systemic hypotension3-5 and this side effect frequently preeludes the administration of a therapeutically effective dose. In addition, both procaine and procaine amide have been shown experimentally to impair myocardial contractile force and to lower cardiac output and systemic arterial pressure. 3' 4, 
Methods
Physiologic studies were performned in 12 patients undergoing corrective cardiac operations. The patients ranged in age from 6 to 48 years; their cardiovascular anomnalies were atrial septal defeet (five patients) ; ventricular septal defect (three patients); valvular pulmonic stenosis (three patients) ; and acquired aortic stenosis (one patient). All patients were receiving maintenance doses of digoxin at the time of study and all were in normal sinus rhythm. After preanesthetic medication, anesthesia was induced with sodium thiamylal or halothane and was maintained with nitrous oxide, oxygen, and halothane in a concentration of 0.5 to 1.0 per cent. Systemic arterial pressure was recorded from a catheter in the radial artery. After the heart had been exposed, a bipolar stimulating electrode* and a WaltonBrodie strain-gage arch'2 were sutured to the right ventricle. The signal from the arch was r-ecorded with the arterial pressure pulse and electrocardiogram on a multi-channel oscillograph. Ventricular excitability was assessed by delivering electrical stimuli of 2-msee. duration to the heart at various In the 6-mnonth period in which the above physiologic studies were being carried out, lidocaine was There was no systematic or significant change in heart rate following the administration of either drug; the maxinlum increase in rate was 12 beats per minute and the maximum decrease was 7 beats per minute. No alteration in the configuration or duration of the QRS complex occurred in any patient after either lidocaine or procaine amide.
Ventricular Excitability
The changes in diastolic threshold that occurred after the administration of lidocaine and procaine amide are illustrated in figure  3 . The current required to produce a ventricular premature contraction during diastole was increased from an average of 1 The changes in the relative duration of the absolute refractory period noted after the administration of lidocaine and procaine amide are shown in figure 4. As noted above, the changes are expressed as fractions of the R-R interval to compensate for the small changes in heart rate that occurred in some patients. Neither drug caused a significant alteration in the duration of the absolute refractory period; the maximum increase and decrease were +5 and -2 per cent of the cycle length, respectively. In the seven patients given lidocaine, the actual duration of the absolute refractory period averaged 244 msee. during the control period and increased to averages of 253 and 264 msee. after 1 The doses of lidocaine and procaine amide employed in the present studies were chosen because they were considered comparable to those which have been shown to be effective in the clinical treatment of ventricular arrhythmia. Both compounds were found to decrease the susceptibility of the ventriele to electrical stimulation, but lidocaine must be considered the more effective agent, sinee snialler doses of it were required to elevate the diastolic threshold and significant depression of arterial pressure and mnyocardial contractile force did not occur after its administration. Although hypotension may result from larger doses of lidocaine17 18 experimental studies in both man and in aninmals have shown that doses similar to those given to these patients cause no circulatory depression.9 ' 11, 19, 20 In contrast, the depressive effects of procaine and procaine amide on the circulation are well known to all physicians who have employed these drugs in the treatment of arrhythmias, and they have also been documented experimentally in animals and in man.3-5 Every patient in the present study, for example, who was given procaine amide, either 2.0 or 4.0 mng./Kg., evidenced a fall in arterial pressure and a decrease in the contractile force of the right ventricle.
The physiologic observations on which this report is based were, of course, made in patients who had congenital or acquired heart disease severe enough to necessitate an open corrective operation and in whom the regulatory niechanisms of the circulation may have been altered or impaired by the circumstances Circulation, Volume XXVIII, October 196.3 LIDOCAINE AND PROCAINE AiMIDE of the operation and the anesthetic state. These, however, are the types of patients and the circumstances in which ventricular arrhythmias most often occur and in which treatment may be life-saving. In therapeutically effective doses, lidocaine was found to decrease ventricular excitability and to have no adverse effects on the circulation. It is concluded, therefore, that lidocaine is the drug of preference for the treatment of ventricular arrhythmia in patients undergoing cardiac operations.
Summary
The effects of lidocaine (Xylocaine) and procaine amide on arterial pressure, myocardial contractile force, and ventricular excitability were studied in 12 patients undergoing cardiac operations. Both compounds resulted in an increase in the stimulation threshold of the ventricle during diastole and neither caused a significant change in the duration of the absolute refractory period. Lidocaine, in doses of 1.0 to 2.0 mg./Kg., produced no significant circulatory depression but every patient given procaine amide (2.0 or 4.0 mg./ Kg.) evidenced a fall in arterial pressure and a decrease in the contractile force of the right ventricle. These physiologic observations and clinical experiences with the use of lidocaine indicate that it is an effective antiarrhythmic agent and that it is preferable to procaine amide in the management of ventricular arrhythmias that occur during and following cardiac operations.
